Background:
Congenital hypogonadotropic hypogonadism (CHH) is a rare genetic disease caused by Gonadotropin-Releasing Hormone (GnRH) deficiency. So far a limited number of variants in several genes have been associated with the pathogenesis of the disease. In this original research and review manuscript the retrospective analysis of known variants in
ANOS1
(
KAL1), RNF216, WDR11, FGFR1, CHD7
, and
POLR3A
genes is described, along with novel variants identified in patients with CHH by the present study.
Methods:
Seven GnRH deficient unrelated Cypriot patients underwent whole exome sequencing (WES) by Next Generation Sequencing (NGS). The identified novel variants were initially examined by
in silico
computational algorithms and structural analysis of their predicted pathogenicity at the protein level was confirmed.
Results:
In four non-related GnRH males, a novel X-linked pathogenic variant in
ANOS1
gene, two novel autosomal dominant (AD) probably pathogenic variants in
WDR11
and
FGFR1
genes and one rare AD probably pathogenic variant in
CHD7
gene were identified. A rare autosomal recessive (AR) variant in the
SRA1
gene was identified in homozygosity in a female patient, whilst two other male patients were also, respectively, found to carry novel or previously reported rare pathogenic variants in more than one genes;
FGFR1
/
POLR3A
and
SRA1/RNF216
.
Conclusion:
This report embraces the description of novel and previously reported rare pathogenic variants in a series of genes known to be implicated in the biological development of CHH. Notably, patients with CHH can harbor pathogenic rare variants in more than one gene which raises the hypothesis of locus-locus interactions providing evidence for digenic inheritance. The identification of such aberrations by NGS can be very informative for the management and future planning of these patients.